Johnson CE[au] - Search Results

Year	Number of Results
1920	1
1931	1
1932	2
1946	1
1948	3
1949	1
1950	2
1951	1
1952	1
1953	1
1955	1
1956	2
1957	1
1958	2
1959	2
1960	4
1961	1
1962	3
1963	1
1964	4
1965	3
1966	4
1967	10
1968	7
1969	5
1970	2
1971	7
1972	8
1973	3
1974	4
1975	6
1976	3
1977	7
1978	6
1979	4
1980	7
1981	2
1982	11
1983	5
1984	6
1985	6
1986	7
1987	8
1988	7
1989	9
1990	10
1991	12
1992	13
1993	9
1994	5
1995	9
1996	6
1997	9
1998	12
1999	12
2000	9
2001	5
2002	12
2003	8
2004	13
2005	15
2006	12
2007	16
2008	22
2009	14
2010	18
2011	20
2012	17
2013	16
2014	12
2015	16
2016	17
2017	20
2018	36
2019	26
2020	30
2021	29
2022	21

1

SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801.

Wahl A, Gralinski LE, Johnson CE, Yao W, Kovarova M, Dinnon KH 3rd, Liu H, Madden VJ, Krzystek HM, De C, White KK, Gully K, Schäfer A, Zaman T, Leist SR, Grant PO, Bluemling GR, Kolykhalov AA, Natchus MG, Askin FB, Painter G, Browne EP, Jones CD, Pickles RJ, Baric RS, Garcia JV. Wahl A, et al. Among authors: johnson ce. Nature. 2021 Mar;591(7850):451-457. doi: 10.1038/s41586-021-03312-w. Epub 2021 Feb 9. Nature. 2021. PMID: 33561864 Free PMC article.

2

Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors.

Hargadon KM, Johnson CE, Williams CJ. Hargadon KM, et al. Among authors: johnson ce. Int Immunopharmacol. 2018 Sep;62:29-39. doi: 10.1016/j.intimp.2018.06.001. Epub 2018 Jul 2. Int Immunopharmacol. 2018. PMID: 29990692 Review.

3

Author reply.

Johnson CE, Slavova-Azmanova N, Saunders C. Johnson CE, et al. Intern Med J. 2018 Feb;48(2):231-232. doi: 10.1111/imj.13705. Intern Med J. 2018. PMID: 29415359 No abstract available.

4

Real-World Evidence for Equality.

Johnson CE, Whiteside YO. Johnson CE, et al. Health Equity. 2021 Oct 6;5(1):724-726. doi: 10.1089/heq.2020.0136. eCollection 2021. Health Equity. 2021. PMID: 34909542 Free PMC article.

5

Management of hypophosphatemia.

Lloyd CW, Johnson CE. Lloyd CW, et al. Among authors: johnson ce. Clin Pharm. 1988 Feb;7(2):123-8. Clin Pharm. 1988. PMID: 3280219 Review.

6

Toward the Future of Early Intervention for Adult Hearing Loss.

Johnson CE, Barbee CM, Danhauer JL, Jilla AM, Kimball SH, Seever KL. Johnson CE, et al. Semin Hear. 2018 May;39(2):221-226. doi: 10.1055/s-0038-1641745. Epub 2018 Jun 15. Semin Hear. 2018. PMID: 29915455 Free PMC article. Review.

7

Characterization of Luminescent Materials with ¹⁵¹Eu Mössbauer Spectroscopy.

Steudel F, Johnson JA, Johnson CE, Schweizer S. Steudel F, et al. Among authors: johnson ce. Materials (Basel). 2018 May 17;11(5):828. doi: 10.3390/ma11050828. Materials (Basel). 2018. PMID: 29772832 Free PMC article. Review.

8

Chemotherapy-induced peripheral neuropathy: a review of recent findings.

Kim PY, Johnson CE. Kim PY, et al. Among authors: johnson ce. Curr Opin Anaesthesiol. 2017 Oct;30(5):570-576. doi: 10.1097/ACO.0000000000000500. Curr Opin Anaesthesiol. 2017. PMID: 28708674 Review.

9

The Sandbox: Development and Implementation of a Technology-Enhanced Classroom.

Logan RM, Johnson CE, Worsham J. Logan RM, et al. Among authors: johnson ce. Nurs Educ Perspect. 2020 Sep/Oct;41(5):E50-E51. doi: 10.1097/01.NEP.0000000000000522. Nurs Educ Perspect. 2020. PMID: 31232881

10

Exploiting cancer vulnerabilities: mTOR, autophagy, and homeostatic imbalance.

Johnson CE, Tee AR. Johnson CE, et al. Essays Biochem. 2017 Dec 12;61(6):699-710. doi: 10.1042/EBC20170056. Print 2017 Dec 12. Essays Biochem. 2017. PMID: 29233879 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results